Lamotrigine
Product Images NDC 53002-2513

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 53002-2513). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (6b93b93c 685b 4ca0 8663 A9e90273c423 740 1)

This text is a company name, "UNICHEM PHARMACEUTICALS (USA). INC."*

FDA Label Image

Image (6b93b93c 685b 4ca0 8663 A9e90273c423 789 2)

Not available.*

FDA Label Image

Image (6b93b93c 685b 4ca0 8663 A9e90273c423 789 3)

FDA Label Image

Molecular Structure (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 01)

FDA Label Image

Figure 1 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 02)

This appears to be a table or graph showing the failure probability percentage for some type of data. The only data visible is that there is a 0% failure probability. Not much else can be interpreted from this limited text.*

FDA Label Image

Figure 2 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 03)

FDA Label Image

Label Image (Lbl530022513)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.